Fenoverine

DB13042InvestigationalSmall molecule

Fenoverine is a phenothiazine based anti-spasmodic agent indicated in the treatment of irritable bowel syndrome.

Chemical structure of Fenoverine
Formula / weight
C26H25N3O3S · 459.56 g/mol (avg)

Resolves to

Compound
UNIIN274ZQ6PZJCAS37561-27-6ChEMBLCHEMBL1512949ChEBI135744PubChem72098
Clinical / RWD
RxNorm24855ATCA03AX05
Structure
InChIKeyUBAJTZKNDCEGKL-UHFFFAOYSA-NSMILESO=C(CN1CCN(CC2=CC3=C(OCO3)C=C2)CC1)N1C2=CC=CC=C2SC2=CC=CC=C12

What you can answer from here — as of June 12, 2021

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
13ContraindicationsEach with its own population and attribute set
Sign in
3Marketed productsAcross 1 country and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 7 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Fenoverine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In